Southern New Hampshire Diabetes and Endocrinology is a clinical research site located in Nashua, New Hampshire, United States 03063.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Southern New Hampshire Diabetes and Endocrinology has participated in 15 clinical trials with 1 currently active.
Therapeutic areas: Type2 Diabetes, Dyslipidemia, Diabetes Mellitus, Type 2.
Sponsors: Kowa Research Institute, Inc., Novo Nordisk A/S, Eli Lilly and Company.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Southern New Hampshire Diabetes and Endocrinology has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Southern New Hampshire Diabetes and Endocrinology has 15 clinical trials on record, with 1 currently active. Their work covers Type2 Diabetes, Dyslipidemia, Diabetes Mellitus, Type 2.
Yes — Southern New Hampshire Diabetes and Endocrinology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.